NightSip Opens the Batch 2 Waitlist After Selling Out Its First Launch

MIAMI, FL — March 6, 2026 — NightSip Inc. has opened the Batch 2 waitlist for its overnight oral care beverage ahead of the next shipment scheduled for April 15, 2026. More than 4,800 customers are already in line after the initial launch sold out.

NightSip was created by founder Hana Ader after a 3 AM moment with her daughter revealed how little traditional oral care does while people sleep.

"I brush twice a day, I floss, I use that burning blue mouthwash that makes my eyes water," said Ader, Founder and CEO of NightSip Inc. "And my five-year-old just told me I have dragon breath at 3 AM. That's when it hit me — mouthwash doesn't work while you sleep."

The Problem NightSip Is Addressing

Morning breath affects virtually every adult, yet most products stop working long before the night is over. Alcohol-based rinses can also dry out the mouth, which makes the overnight problem worse.

After 52 failed formulations, Ader landed on a blend of:

• 9.5 pH alkaline water
• liquid chlorophyll
• aloe vera
• zinc gluconate
• lemon juice
• monk fruit

The result is an alcohol-free, zero-calorie beverage designed to be sipped before bed and work gently through the night.

Batch 2 Waitlist Details

NightSip launched direct to consumer at ${(COMMERCE_POLICY.pricing.casePrice / 100).toFixed(2){'}'} per case of 12 bottles and sold out its first batch. The Batch 2 waitlist is now open.

Waitlist members receive:

• first access when the next batch drops
• 20% off their first order
• the latest product and shipping updates

The next shipment is scheduled for April 15, 2026.

About NightSip

NightSip is an oral care beverage designed to naturally freshen breath while you sleep. Founded in 2024 by Hana Ader in Miami, Florida, NightSip combines 9.5 pH alkaline water, zinc, liquid chlorophyll, aloe vera, lemon juice, and monk fruit to create a safe-to-swallow alternative to traditional mouthwash.

For media resources, product images, founder materials, and contact information, visit [the press kit](/press).

For first access to the next batch, [join the waitlist](/waitlist).